Kite Pharma

Activities: Research & Development Pharmaceutical

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to...
  2. Resolving capping issues in tablet manufacturing Natoli explores the various causes of capping and the methods to prevent it
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Industrial data mastery: navigating the 2025 landscape As industrial manufacturers contend with the ever-increasing volume and variety of operational data, the year ahead promises both complexity and opportunity
  5. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

Related Content

Design & Build

Kite to build plant for cell therapies portfolio in California

A 67,000-square-foot facility will be built within an existing Gilead biologics production site in Oceanside
Design & Build

Kite to build new manufacturing plant for CAR-T therapies in the US

The 20-acre site located in Maryland will produce cell therapies for people with cancer
Pharmaceutical

Fosun Kite Biotechnology appoints new CEO

Richard L. Wang Named Chief Executive Officer of Fosun Kite Biotechnology, part of Kite Pharma
You need to be a subscriber to read this article.
Click here to find out more.
Research & Development

Homing in on cancer targets

Traditional cancer treatments like chemo- and radiotherapy are blunt instruments. Dr Sarah Houlton looks at developments in CAR T-cell technology, which promises a much more precise approach
Subscribe now